Join
Live feed
·
INSIDERFilingvia Quantisnow
Gemini Therapeutics Inc. logo

SEC Form 3: New insider Atlas Venture Opportunity Fund Ii, L.P. claimed ownership of 218,326 shares

ByQuantisnow·Wall Street's wire, on your screen.
GMTX· Gemini Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GMTX (Gemini Therapeutics Inc.) and more on Quantisnow.